Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paolo Pezzella
Institution:
University of Naples Federico II
Observed institution:
University of Naples Federico II
ORCID:
0009-0005-7237-2641
Observed ORCID:
0009-0005-7237-2641
OpenAlex ID:
A5111220180
The Effects of Mepolizumab on CRSwNP: Real-Life Evidence
2024
·
Elena Cantone
, Bernardino Cassiano
, et al.
·
Journal of Personalized Medicine
·
10
PDF
TAS2R38 genotype and CRS severity in children with cystic fibrosis
2025
·
Elena Cantone
, Antonella Tosco
, et al.
·
Heliyon
·
7
Dupilumab-Related Hypereosinophilia in Patients Treated for Type 2 Diseases: Evidence from a 24-Month Prospective Real-Life Study
2026
·
Ilaria Mormile
, Daniele La Prova
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Short-term effectiveness of tezepelumab on ENT manifestations in patients undergoing treatment for severe asthma: A pilot real-life study
2026
·
Elena Cantone
, Paolo Pezzella
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
2
Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial
2026
·
Eugenio De Corso
, Giancarlo Ottaviano
, et al.
·
The Lancet Respiratory Medicine
·
1
In Reference to Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
2024
·
Elena Cantone
, Paolo Pezzella
, et al.
·
The Laryngoscope
Show more works
View as search
Works count:
6
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type